PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases

Annals of Clinical and Laboratory Science

Volumn 33, Issue 3, 2003, Pages 320-323

  Aksoy, Yilmaz ^a   Oral, Aytekin ^a   Aksoy, Hulya ^a   Demirel, Azam ^a   Akcay, Fatih ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Benign prostatic hyperplasia; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

AGED; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0041941591     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Silverberg E, Boring CC, Squeres TS. Cancer statistics, 1990. CA Cancer J Clin 1990;40:9-26.
2. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358-1368.
3. Maede H, Arai Y, Ishitoya S, Okubo K, Aoki Y, Okada T. Prostate specific antigen adjusted for the transition zone volume as an indicator of prostate cancer. J Urol 1997;158:2193-2196.
4. Zlotta AR, Djavan B, Marberger M, Schulman CC. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J Urol 1997;157:1315-1321.
5. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl J Med 1991;324:1156-1161.
6. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992;147:841-845.
7. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-821.
8. Bretton PR, Evans WB, Borden JD, Castellanos RD. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Cancer 1994;74:2991-2995.
9. Gustafsson O, Mansour E, Norming U, Carlsson A, Törnblom M, Nyman CR. Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer. Scand J Urol Nephrol 1998;32:373-377.
10. Mettlin C, Littrup PJ, Kane RJ, Murphy GP, Lee F, Chesley A, Badalament R, Mostofi FK. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density and PSA change. Cancer 1994;74:1615-1620.
11. Cookson MS, Floyd MK, Ball TP Jr, Miller EK, Sarosdy MF. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol 1995;154:1070-1073.
12. Men S, Cakar B, Conkbayir I, Hekimoglu B. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. J Exp Clin Cancer Res 2001;20:473-480.
13. Hammerer PG, McNeal JE, Stamey TE. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate. J Urol 1995;153:111-114.
14. Kurita Y, Ushiyama T, Suzuki K, Fujita K, Kawabe K. PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer. Int J Urol 1996;3:367-372.
15. Kikuchi E, Nakashima J, Ishibashi M, Ohigashi T, Asakura H, Tachibana M, Murai M. Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma. Cancer 2000;89:842-849.
16. Furuya Y, Ohta S, Sato N, Kotake T, Sugano I, Nagao K, Masai M. Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels. Anticancer Res 2001;21:1317-1320.
17. Lepor H, Wang B, Shapiro E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology 1994;44:199-205.
18. Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J Urol 1998;160:77-82.
19. Egawa S, Suyama K, Matsumoto K, Kuwao S, Baba S. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples. J Urol 2002;167:97-102.